Geron Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GERON
GERON has one approved drug.
There are six US patents protecting GERON drugs.
There are one hundred and sixty-one patent family members on GERON drugs in thirty-eight countries and ten supplementary protection certificates in ten countries.
Summary for Geron
| International Patents: | 161 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Geron
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-001 | Jun 6, 2024 | RX | Yes | Yes | 12,171,778 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-001 | Jun 6, 2024 | RX | Yes | Yes | 9,388,416 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-002 | Jun 6, 2024 | RX | Yes | Yes | 9,388,415 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Geron | RYTELO | imetelstat sodium | POWDER;INTRAVENOUS | 217779-001 | Jun 6, 2024 | RX | Yes | Yes | 9,388,415 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Geron Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Lithuania | PA2025517 | ⤷ Start Trial |
| Cyprus | 1122169 | ⤷ Start Trial |
| New Zealand | 748134 | ⤷ Start Trial |
| Hungary | E048359 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Geron Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3456333 | LUC50005 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: IMETELSTAT, OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; AUTHORISATION NUMBER AND DATE: EU/1/24/1894 20250311 |
| 3456333 | 301326 | Netherlands | ⤷ Start Trial | PRODUCT NAME: IMETELSTAT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/24/1894 20250311 |
| 3456333 | C202530024 | Spain | ⤷ Start Trial | PRODUCT NAME: IMETELSTAT, O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/24/1894; DATE OF AUTHORISATION: 20250307; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/24/1894; DATE OF FIRST AUTHORISATION IN EEA: 20250307 |
| 3456333 | CR 2025 00016 | Denmark | ⤷ Start Trial | PRODUCT NAME: IMETELSTAT, ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/24/1894 20250311 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
